92 related articles for article (PubMed ID: 29061792)
21. Leptin acts on neoplastic behavior and expression levels of genes related to hypoxia, angiogenesis, and invasiveness in oral squamous cell carcinoma.
Sobrinho Santos EM; Guimarães TA; Santos HO; Cangussu LMB; de Jesus SF; Fraga CAC; Cardoso CM; Santos SHS; de Paula AMB; Gomez RS; Guimarães ALS; Farias LC
Tumour Biol; 2017 May; 39(5):1010428317699130. PubMed ID: 28459203
[TBL] [Abstract][Full Text] [Related]
22. Anti-tumor effect of a novel FAK inhibitor TAE226 against human oral squamous cell carcinoma.
Kurio N; Shimo T; Fukazawa T; Okui T; Hassan NM; Honami T; Horikiri Y; Hatakeyama S; Takaoka M; Naomoto Y; Sasaki A
Oral Oncol; 2012 Nov; 48(11):1159-70. PubMed ID: 22766511
[TBL] [Abstract][Full Text] [Related]
23. p12CDK2-AP1 interacts with CD82 to regulate the proliferation and survival of human oral squamous cell carcinoma cells.
Chai J; Ju J; Zhang SW; Shen ZY; Liang L; Yang XM; Ma C; Ni QW; Sun MY
Oncol Rep; 2016 Aug; 36(2):737-44. PubMed ID: 27349208
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of H3K9 methyltransferase G9a induces autophagy and apoptosis in oral squamous cell carcinoma.
Ren A; Qiu Y; Cui H; Fu G
Biochem Biophys Res Commun; 2015 Mar; 459(1):10-7. PubMed ID: 25634693
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effect of aloe emodin mediated photodynamic therapy on human oral mucosa carcinoma in vitro and in vivo.
Liu YQ; Meng PS; Zhang HC; Liu X; Wang MX; Cao WW; Hu Z; Zhang ZG
Biomed Pharmacother; 2018 Jan; 97():697-707. PubMed ID: 29102913
[TBL] [Abstract][Full Text] [Related]
26. Synergistic Effect of Sorafenib and Radiation on Human Oral Carcinoma in vivo.
Hsu FT; Chang B; Chen JC; Chiang IT; Liu YC; Kwang WK; Hwang JJ
Sci Rep; 2015 Oct; 5():15391. PubMed ID: 26487364
[TBL] [Abstract][Full Text] [Related]
27. Anti-tumor effect of cisplatin in human oral squamous cell carcinoma was enhanced by andrographolide via upregulation of phospho-p53 in vitro and in vivo.
Chen S; Hu H; Miao S; Zheng J; Xie Z; Zhao H
Tumour Biol; 2017 May; 39(5):1010428317705330. PubMed ID: 28513299
[TBL] [Abstract][Full Text] [Related]
28. Tivantinib (ARQ-197) exhibits anti-tumor activity with down-regulation of FAK in oral squamous cell carcinoma.
Xi WH; Yang LY; Cao ZY; Qian Y
Biochem Biophys Res Commun; 2015 Feb; 457(4):723-9. PubMed ID: 25623532
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic potential of targeting cell division cycle associated 5 for oral squamous cell carcinoma.
Tokuzen N; Nakashiro K; Tanaka H; Iwamoto K; Hamakawa H
Oncotarget; 2016 Jan; 7(3):2343-53. PubMed ID: 26497678
[TBL] [Abstract][Full Text] [Related]
30. Muc-1 promotes migration and invasion of oral squamous cell carcinoma cells via PI3K-Akt signaling.
Li P; Xiao LY; Tan H
Int J Clin Exp Pathol; 2015; 8(9):10365-74. PubMed ID: 26617744
[TBL] [Abstract][Full Text] [Related]
31. The clock gene PER1 suppresses expression of tumor-related genes in human oral squamous cell carcinoma.
Li HX; Fu XJ; Yang K; Chen D; Tang H; Zhao Q
Oncotarget; 2016 Apr; 7(15):20574-83. PubMed ID: 26943040
[TBL] [Abstract][Full Text] [Related]
32. Human telomerase reverse transcriptase is a promising target for cancer inhibition in squamous cell carcinomas.
Park YJ; Kim EK; Moon S; Hong DP; Bae JY; Kim J
Anticancer Res; 2014 Nov; 34(11):6389-95. PubMed ID: 25368238
[TBL] [Abstract][Full Text] [Related]
33. Transcutaneous carbon dioxide induces mitochondrial apoptosis and suppresses metastasis of oral squamous cell carcinoma in vivo.
Takeda D; Hasegawa T; Ueha T; Imai Y; Sakakibara A; Minoda M; Kawamoto T; Minamikawa T; Shibuya Y; Akisue T; Sakai Y; Kurosaka M; Komori T
PLoS One; 2014; 9(7):e100530. PubMed ID: 24988190
[TBL] [Abstract][Full Text] [Related]
34. Abrus agglutinin targets cancer stem-like cells by eliminating self-renewal capacity accompanied with apoptosis in oral squamous cell carcinoma.
Sinha N; Panda PK; Naik PP; Maiti TK; Bhutia SK
Tumour Biol; 2017 May; 39(5):1010428317701634. PubMed ID: 28459216
[TBL] [Abstract][Full Text] [Related]
35. Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice.
Shalinsky DR; Bischoff ED; Gregory ML; Gottardis MM; Hayes JS; Lamph WW; Heyman RA; Shirley MA; Cooke TA; Davies PJ
Cancer Res; 1995 Jul; 55(14):3183-91. PubMed ID: 7541715
[TBL] [Abstract][Full Text] [Related]
36. Metformin in combination with 5-fluorouracil suppresses tumor growth by inhibiting the Warburg effect in human oral squamous cell carcinoma.
Harada K; Ferdous T; Harada T; Ueyama Y
Int J Oncol; 2016 Jul; 49(1):276-84. PubMed ID: 27210058
[TBL] [Abstract][Full Text] [Related]
37. [A pilot study on hypoxia of squamous cell carcinoma in oral cavity].
Liu WS; Shang JW; Gao Y; Guo CB
Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 May; 44(5):282-5. PubMed ID: 19575985
[TBL] [Abstract][Full Text] [Related]
38. Transforming growth factor-β synthesized by stromal cells and cancer cells participates in bone resorption induced by oral squamous cell carcinoma.
Nakamura R; Kayamori K; Oue E; Sakamoto K; Harada K; Yamaguchi A
Biochem Biophys Res Commun; 2015 Mar; 458(4):777-82. PubMed ID: 25681764
[TBL] [Abstract][Full Text] [Related]
39. Correlation of invasion and metastasis of cancer cells, and expression of the RAD21 gene in oral squamous cell carcinoma.
Yamamoto G; Irie T; Aida T; Nagoshi Y; Tsuchiya R; Tachikawa T
Virchows Arch; 2006 Apr; 448(4):435-41. PubMed ID: 16416296
[TBL] [Abstract][Full Text] [Related]
40. Expression of Cyr61 (CCN1) in human oral squamous cell carcinoma: An independent marker for poor prognosis.
Kok SH; Chang HH; Tsai JY; Hung HC; Lin CY; Chiang CP; Liu CM; Kuo MY
Head Neck; 2010 Dec; 32(12):1665-73. PubMed ID: 20848406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
